dr. wierda on ibrutinib plus venetoclax in cll
Published 7 years ago • 950 plays • Length 1:16Download video MP4
Download video MP3
Similar videos
-
2:11
dr. wierda on ibrutinib resistance in cll
-
1:25
dr. wierda discusses the role of ibrutinib in cll
-
1:42
dr. wierda on combination regimens with venetoclax in cll
-
0:56
dr. chavez discusses ibrutinib plus venetoclax in cll
-
7:20
adding venetoclax to ibrutinib for cll patients with high-risk disease - dr. bill wierda ash 2021
-
4:46
support shown for fixed-duration combination ibrutinib venetoclax for cll patients
-
1:38
dr. william g. wierda on role for ibrutinib in frontline cll
-
2:28
william wierda | ibrutinib and venetoclax combination for first-line cll: captivate phase ii trial
-
1:07
ibrutinib plus venetoclax as a treatment option for cll
-
1:36
dr. logan discusses ibrutinib plus venetoclax in cll
-
1:29
dr. wierda on novel therapies in relapsed/refractory cll
-
1:10
dr. wierda on frontline management of patients with cll
-
2:07
dr. wierda on factors to consider in frontline management of cll
-
1:05
dr. smith on using venetoclax versus ibrutinib in cll
-
1:15
dr. wierda discusses sequencing new agents in cll
-
0:54
dr. davids discusses ongoing research with ibrutinib plus venetoclax in cll
-
1:34
captivate study: outcomes in patients with umrd following cessation of ibrutinib plus venetoclax
-
2:19
dr. wierda discusses trials of novel combinations in cll
-
1:21
dr. pleyer on ongoing research with ibrutinib plus venetoclax in cll